Tag: SGS

SGS Launches its First Malaria VIS

SGS, a leading life-sciences, clinical and bioanalytical contract solutions provider, announced that it will commence its first Malaria Volunteer Infection Study (VIS) in Belgium in February 2019 on b...

SGC Invests £7.6m to Expand Testing Capabilities

Clients will benefit from a fully comprehensive range of validated biosafety methods to support cell bank and viral vaccine manufacturing and lot release of drug product. SGS has invested £7.6 mill...

SGS to increase bioanalytical Capabilities by 2020

The €3.5 million investment in equipment, facilities and expert staff will significantly increase the capabilities at the site to match increasing demand and shorten processes for pharmaceutical clien...

SGS boosts its capabilities in infectious disease therapeutics and vaccines

SGS announced that it has successfully implemented advanced techniques for the collection and use of Peripheral Blood Mononuclear Cells (PBMCs) for early phase clinical trials.

SGS starts new large molecule bioanalytical services

SGS is now offering clients large molecule bioanalytical services at its laboratory in Wavre, Belgium